Proteinuria and its assessment in normal and hypertensive pregnancy

doi:10.1016/S0002-9378(11)91578-6

American Journal of Obstetrics and Gynecology

Volume 167, Issue 3, September 1992, Pages 723-728

https://doi.org/10.1016/S0002-9378(11)91578-6 Get rights and content

OBJECTIVES: The purposes of this study were (1) to determine 24-hour urinary protein excretion rates in normal human pregnancy and (2) to assess the reliability of assessment of proteinuria by dipstick measurement.

STUDY DESIGN: At 17 to 20 and 33 to 36 weeks of pregnancy, 174 normal volunteers collected a 24-hour urine sample; the volume and the protein and creatinine concentrations were measured. The result for protein was compared with dipstick analysis of an early morning midstream urine sample collected at the conclusion of the 24-hour period. Sixty-eight consecutive inpatients admitted to the antenatal ward with hypertension and positive urine dipstick tests for protein underwent the same procedure. The interobserver variability in dipstick analyses of urine samples of known protein content was assessed with the aid of 66 volunteers from the hospital staff.

RESULTS: The upper 95% confidence limit of the normal population was <200 mg per 24 hours, at both stages of pregnancy investigated. In these women and in the hypertensive inpatients a high proportion of false-positive and false-negative results was found with dipstick analyses. Interobserver variation in assessment of proteinuria by dipstick was high, with an 18% false-positive rate and a false-negative rate approaching 40% for samples with 30 mg/dl. Even in the presence of 100 mg/dl the false-negative rate was 7%, whereas the concentration of protein was significantly underestimated in 20% of samples with 500 mg/dl.

CONCLUSION: Dipstick urinalysis cannot be relied on either to detect or to exclude the presence of proteinuria in pregnant women.

References (13)

AB Lorincz et al.
Protein excretion patterns in pregnancy
Am J Obstet Gynecol
(1961)
EDM Gallery et al.
Glomerular and proximal renal tubular function in pregnancy-associated hypertension: a prospective study
Eur J Obstet Gynecol Reprod Biol
(1979)
EDM Gallery et al.
Urinary concentration, white cell excretion and acid-base status in normal pregnancy: alterations in pregnancy-associated hypertension
Am J Obstet Gynecol
(1979)
E Simpson et al.
Routine urinalysis
Lancet
(1977)
CA Eiden et al.
The Addis sediment count and blood urea clearance test in normal pregnant women
J Clin Invest
(1935)
WJ Dieckmann

There are more references available in the full text version of this article.

Cited by (103)

A meta-analysis on diagnostic accuracy of spot urinary protein to creatinine ratio versus 12-h proteinuria in preeclampsia
2024, iScience
To systematically review the diagnostic accuracy of spot urinary protein to creatinine ratio (PCR) and 12-h proteinuria in preeclampsia and to estimate which is a preferred alternative method for 24-h proteinuria, we carried out this meta-analysis. 25 primary studies were included based on searching strategy. For spot urinary PCR, our results showed pooled sensitivity of 87% (95% confidence interval [CI] 83%–91%) and specificity of 86% (95% CI 79%–91%), with an area under curve (AUC) of 0.93 (0.90–0.95). For 12-h proteinuria, pooled sensitivity and specificity were 92% (95% CI 87%–96%) and 99% (95% CI 75%–100%), respectively, with an AUC of 0.97 (0.95–0.98). Fagan plot and likelihood ratio scattergram showed that 12-h proteinuria yielded a better discriminatory performance on diagnosis of proteinuria (≥0.3 g/24 h). These results indicated that 12-h proteinuria estimation shows better clinical value than spot urine PCR for diagnosis of preeclampsia. However, due to the severity of condition and the fact that preeclampsia patients cannot wait for 12 h, spot urine PCR can be used as one of the diagnostic indicators.
Twenty-four-hour urinary protein excretion in uncomplicated singleton pregnancy
2024, American Journal of Obstetrics and Gynecology
Twenty-four-hour urinary total protein excretion is an essential parameter used for evaluation of renal function and early detection of gestational complications. However, data on reference ranges of 24-hour urinary total protein excretion in normal pregnancy are scarce.
This study aimed to determine reference ranges for 24-hour urinary total protein excretion in a population with uncomplicated singleton pregnancies using a standard method for urinary total protein. In addition, the values of 24-hour urinary total protein were stratified by maternal age and prepregnancy body mass index.
This study was based on a prospective cohort study in Shenzhen, China. The pregnant women were enrolled at their first prenatal clinical visit. All the participants were instructed to collect 24-hour urine samples during the following successive gestational periods: 6⁺⁰ to 13⁺⁶, 14⁺⁰ to 27⁺⁶, and 28⁺⁰ to 41⁺⁶ weeks. Total urinary protein excretion was analyzed by a colorimetric method. Ultimately, the study encompassed a total of 4844 pregnant women with uncomplicated pregnancies. The nonparametric percentile method was used to determine reference ranges for 24-hour urinary total protein excretion during different trimesters in women with uncomplicated pregnancies (excluding those with previous kidney disorders, gestational or chronic hypertension, preeclampsia, and pregestational diabetes mellitus, among others).
The 24-hour urinary total protein levels expressed as medians and percentiles (5th, 95th) for each trimester were as follows: 72.0 (28.4, 165.0), 88.0 (34.0, 185.0), and 108.0 (37.5, 258.0) mg in the first, second, and third trimesters, respectively. A significant increase in 24-hour urinary total protein excretion was observed throughout pregnancy (all P values <.001). Moreover, 24-hour urinary total protein levels were higher in the older (≥35 years) than in the younger (<35 years) group from mid-gestation. Specifically, the median (interquartile range) 24-hour urinary total protein levels by age were 72.2 (50.6–100.0) vs 70.5 (50.5–100.0) mg, 85.8 (62.0–117.0) vs 96.0 (68.0–127.8) mg, and 106.6 (76.0–146.2) vs 114.7 (81.5–153.6) mg in the first, second, and third trimesters, respectively. In addition, 24-hour proteinuria was significantly increased in higher-weight (overweight or obese) subgroups compared with lower-weight (underweight or normal-weight) subgroups (all P values <.05).
Our study provides reference values for 24-hour urinary total protein excretion with apparently uncomplicated pregnancies. Understanding these changes in low-risk pregnancies is essential for optimizing maternal management.
Pregnancy in Autosomal Dominant Polycystic Kidney Disease
2023, Advances in Kidney Disease and Health
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder occurring in approximately 1:1000 individuals. ADPKD is characterized by gradual cyst expansion and kidney enlargement and is a slowly progressive disorder where patients typically initiate renal replacement therapy in the sixth decade of life. The vast majority of women with ADPKD become pregnant in the third or fourth decade, often before knowing that they have ADPKD, in the setting of normal kidney function or chronic kidney disease Stage 1. In ADPKD, pregnancy outcomes for mother and baby differ from the general population, and long-term consequences of maternal complications from pregnancy are common in ADPKD. In the current era of genetic testing, options to consider pre-implantation genetic screening are becoming more available. This chapter will review renal physiologic and anatomic changes that occur in pregnancy, the potential impact of ADPKD on maternal and fetal outcomes, medical management during pregnancy, the impact of pregnancy on long-term outcomes in women with ADPKD, and options for families with ADPKD planning to undergo pregnancy with regard to genetic testing.
Hypertensive Disorders of Pregnancy
2023, Emergency Medicine Clinics of North America
Pregnant biglycan knockout mice have altered cardiorenal adaptations and a shorter gestational length, but do not develop a pre-eclamptic phenotype
2022, Placenta
Pre-eclampsia complicates 4.6% of pregnancies and is linked to impaired placentation; likely due to dysregulated vasculogenesis/angiogenesis. Proteoglycans, such as biglycan, are located on the endothelial surface of fetal capillaries. Biglycan is reduced in the placenta of pregnancies complicated by fetal growth restriction and pre-eclampsia. Importantly, biglycan stimulates angiogenesis in numerous tissues. Therefore, this study investigated whether biglycan knockdown in mice results in a pre-eclamptic phenotype.
Wild-type (WT) and Bgn^-^/^- mice underwent cardiorenal measurements prior to and during pregnancy. One cohort of mice underwent post-mortem on gestational day 18 (E18) and another cohort underwent post-mortem on postnatal day 1 (PN1), with maternal and offspring tissues of relevance collected.
Bgn^-^/^- dams had increased heart rate (+9%, p < 0.037) and reduced systolic (−11%, p < 0.001), diastolic (−15%, p < 0.001), and mean arterial (−12%, p < 0.001) pressures at all ages investigated compared to WT. Additionally, Bgn^-^/^- dams had reduced urine flow rate (−64%, p < 0.001) as well as reduced urinary excretions (−49%, p < 0.004) during late gestation compared to WT. Bgn^-^/^- pups had higher body weight (+8%, p = 0.004; E18 only) and a higher liver-to-brain weight ratio (+43%, p < 0.001). Placental weight was unaltered with only minor changes in vasculogenic and angiogenic gene abundances detected, which did not correlate to changes in protein expression.
This study demonstrated that total knockdown of biglycan is not associated with features of pre-eclampsia.
The evolution of the diagnostic criteria of preeclampsia-eclampsia
2022, American Journal of Obstetrics and Gynecology
As the understanding of the pathophysiology of preeclampsia has improved, its diagnostic criteria have evolved. The classical triad of hypertension, edema, and proteinuria has become hypertension and organ dysfunction—renal, hepatic, neurologic, hematological, or uteroplacental. However, the most recent definitions have largely been based off consensus and expert opinion, not primary research. In this review, we explore how the criteria have evolved, particularly through the second half of the 20^th and the beginning of the 21st century and offer a critical appraisal of the evidence that has led the criteria to where they stand today. Some key themes are the following: the debate between having a simple and convenient blood pressure cutoff vs a blood pressure cutoff that accounts for influencing factors such as age and weight; whether a uniform blood pressure threshold, a rise in blood pressure, or a combination is most discriminatory; whether existing evidence supports blood pressure and proteinuria thresholds in diagnosing preeclampsia; and whether using flow-charts and decision trees might be more appropriate than a single set of criteria. We also discuss the future of a preeclampsia diagnosis. We challenge the move toward a broad (vs restrictive) diagnosis, arguing instead for criteria that directly relate to the prognosis of preeclampsia and the response to treatments.

View all citing articles on Scopus

^a: From the Department of Obstetrics and Gynecology, Royal North Shore Hospital.

^b: From the Department of Renal Medicine, Royal North Shore Hospital.

^c: From the Department of Biochemistry, Royal North Shore Hospital.

View full text

Proteinuria and its assessment in normal and hypertensive pregnancy

Am J Obstet Gynecol

Eur J Obstet Gynecol Reprod Biol

Am J Obstet Gynecol

Lancet

The Addis sediment count and blood urea clearance test in normal pregnant women

J Clin Invest